EPAS1 and neoplasm: Consistent with this, in xenograft assays of CCRCC cells, active HIF-2α is both necessary and sufficient for tumour growth (Kondo et al, 2002, 2003), whereas active HIF-1α is insufficient (Maranchie et al, 2002).